GenSight
PrivateCompany Overview
GenSight operates in Enterprise Software and is based in Paris. It was founded in 2012.
GenSight Biologics is a biopharmaceutical company that develops and commercializes gene therapies for retinal neurodegenerative diseases and central nervous system disorders.
Sector
Enterprise Software
Verticals
Project Management, Business Intelligence, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenSight Comparables
Compare GenSight with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Captario | 77% |
For institutional investors. Book with your work email.
GenSight Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 36% MoM, reaching 3.2K.
- Jan 21, 2026
Monthly visitors increased 51% MoM, reaching 4.1K.
For institutional investors. Book with your work email.
GenSight Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GenSight's valuation, stock price, and market status.
Is GenSight a public or private company?
GenSight is a private company.
What is the current stock price of GenSight?
GenSight is a private company, so its shares have no public market price. Caplight tracks GenSight's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GenSight worth (valuation)?
Valuation information for GenSight is not publicly available.
Can I buy GenSight stock?
GenSight shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GenSight's last funding round?
Funding round information for GenSight is not publicly available.
Who are the main investors in GenSight?
Investor information for GenSight is not publicly disclosed.
Will GenSight IPO soon?
No public IPO plans have been announced for GenSight.
How can I track GenSight secondary market activity?
Caplight tracks bids, offers, and trades in GenSight's shares on secondary markets.